Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Liquidia Technologies (LQDA) Drug Pipeline

843 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Liq861 Inhalation PowderPulmonary Arterial Hypertension (Pah)Phase IVRecruitingA Study of Inhaled Treprostinil (LIQ861) in Adults With Pulmonary Arterial Hypertension Transitioning From Oral SelexipagAug 07, 2026―
Liq861 Inhalation Powder - Dose Titration Arm, Liq861 Inhalation Powder - Fixed Dose Arm, Treprostinil Inhalation Powder, YutrepiaRaynaud's Phenomenon Secondary To Systemic SclerosisPhase IINot Yet RecruitingA Study of LIQ861 (Inhaled Treprostinil) in Adults With Systemic Sclerosis Who Have Symptomatic Raynaud's Phenomenon AttacksJul 31, 2026
L606Pulmonary Hypertension Due To Lung Disease (Disorder)Phase IIIRecruitingA Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILDDec 11, 2025
L606 Inhalation SuspensionPulmonary Arterial Hypertension, Pulmonary Hypertension Due To Lung DiseasesPhase IIIActive Not RecruitingA Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILDDec 21, 2020―
Liq861 Inhaled TreprostinilPrimary Pulmonary HypertensionPhase IIIActive Not RecruitingExtension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry Powder Inhalation of TreprostinilJun 05, 2019―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Liquidia Technologies (LQDA) have in its pipeline
Liquidia Technologies LQDA is currently developing the following drugs: Liq861 Inhalation Powder, Liq861 Inhalation Powder - Dose Titration Arm, Liq861 Inhalation Powder - Fixed Dose Arm, Treprostinil Inhalation Powder, Yutrepia, L606, L606 Inhalation Suspension, Liq861 Inhaled Treprostinil. These drug candidates are in various stages of clinical development as the company works toward FDA approval.